Clinical Trials

Find a Trial

Trial Summary

Protocol No.IUSCC-0565
StatusOPEN TO ACCRUAL
Principal InvestigatorEllsworth, Susannah
ScopeLocal
PhasePilot
Age GroupAdult
TitlePilot study of respiratory-gated stereotactic body radiation therapy for boderline resectable, unresectable, or recurrent/residual adenocarcinoma of the pancreas or periampullary region.
DescriptionTo estimate rates of acute (within 3 months of treatment) grade 3 or greater gastrointestinal and hematologic toxicity in patients treated with Linac-based SBRT for pancreatic or periampullary cancers who have previously received other treatment.
Key EligibilityIn order to be eligible to take part in this trial, patients must have:
  • Pancreatic or periampullary tumors must be less than 8.0 cm in greatest axial dimension at the time of treatment planning.
  • Age >18 years.
For a full list of participation criteria, please visit ClinicalTrials.gov
Applicable Disease SitesPancreatic Cancer
Participating InstitutionsIndiana University (IU)
  • IU Health Methodist Hospital
  • IU Health West (For use by Cancer Center CTO only)
  • Indiana University Hospital / IU Simon Cancer Center
Treatment TypeTreatment
ContactPhone: (317) 278-5632
Email: iutrials@iu.edu